Skip to main content
. Author manuscript; available in PMC: 2019 Jan 27.
Published in final edited form as: Lung. 2014 Aug 8;192(5):811–817. doi: 10.1007/s00408-014-9633-2

Fig. 2.

Fig. 2

Respective concentration-response relation and resultant percent vasorelaxation ([NS1619]= 30μM) of isolated perfused lungs from normoxic (a & b) and hypoxic (c & d) rats (n = 3–6/group) to the BKCa channel activator, NS1619, in the absence (vehicle) and presence of iberiotoxin (Ibtx; 200 nM; membrane BKCa channel inhibitor) and nifedipine (1 μM; L-type Ca2+ channel blocker). Values are means ± SE. *P < 0.05 vs. vehicle. #P < 0.05 vs. Ibtx